23 Jul 2025 KU Leuven researchers identify promising drug for treating severe malaria Multiple categories
30 Jun 2025 argenx Advances Clinical Development of ARGX-119 in Congenital Myasthenic Syndromes Multiple categories
20 Jun 2025 argenx Announces European Commission Approval of VYVGART Subcutaneous Injection for Chronic Inflammatory Demyelinating Polyneuropathy Multiple categories
05 Jun 2025 AstriVax Therapeutics Initiates Clinical Development of AVX70371, a Hepatitis B immunotherapy using Launch-iT technology Multiple categories
21 May 2025 Biovia: the new health innovation cluster for human and planetary health Multiple categories
13 May 2025 Galapagos Announces Strategic Update on Proposed Separation, Executive Leadership Transition and Board Changes Multiple categories
08 May 2025 Biovia: the New Health Innovation Cluster Forging a Path to a Healthier Future for All Multiple categories
07 May 2025 Remynd tests optimized septin modulator against Alzheimer’s disease in phase 1 clinical trial Multiple categories
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us
